Basic Medical Theory Research

[1] 刘明波, 何新叶, 杨晓红, 等. 《中国心血管健康与疾病报告2024》要点解读[J]. 心肺血管病杂志, 2025,44(09):899-917.
[2] Chistyakov D V, Chistyakov V V, Sergeeva M G. Oxylipins in Atherosclerosis: Their Role in Inflammation, Diagnosis, and Therapeutic Perspectives[J]. Int J Mol Sci, 2025,26(21).
[3] Lee S, Sung J M, Andreini D, et al. Association Between Changes in Perivascular Adipose Tissue Density and Plaque Progression[J]. JACC Cardiovasc Imaging, 2022,15(10):1760-1767.
[4] Albano D, Monti C B, Risoleo G A, et al. Correlation of Sarcopenia with Coronary Artery Disease Severity and Pericoronary Adipose Tissue Attenuation: A Coronary CT Study[J]. Tomography (Ann Arbor, Mich.), 2024,10(11):1744-1753.
[5] Karampetsou N, Alexopoulos L, Minia A, et al. Epicardial Adipose Tissue as an Independent Cardiometabolic Risk Factor for Coronary Artery Disease[J]. Cureus, 2022,14(6):e25578.
[6] Kong P, Cui Z, Huang X, et al. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention[J]. Signal Transduct Target Ther, 2022,7(1):131.
[7] Han J, Meng Q, Shen L, et al. Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning[J]. Lipids Health Dis, 2018,17(1):14.
[8] 龙彩凤, 韩昊儒, 邓维炎, 等. IL-6通过STAT3/Oct-1/ATM途径调节人脐静脉平滑肌细胞增殖[J]. 中国细胞生物学学报, 2020,42(08):1314-1324.
[9] Zhao J, Zhang M, Li W, et al. Suppression of JAK2/STAT3 signaling reduces end-to-end arterial anastomosis induced cell proliferation in common carotid arteries of rats[J]. PLoS One, 2013,8(3):e58730.
[10] Rosen C J. Antagonizing the Leptin Receptor in Obesity[J]. N Engl J Med, 2023,388(24):2291-2293.
[11] Yamagishi S I, Edelstein D, Du X L, et al. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A[J]. J Biol Chem, 2001,276(27):25096-25100.
[12] Moradi N, Fouani F Z, Vatannejad A, et al. Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study[J]. Lipids Health Dis, 2021,20(1):88.
[13] Miao Y, Qin H, Zhong Y, et al. Novel adipokine asprosin modulates browning and adipogenesis in white adipose tissue[J]. J Endocrinol, 2021,249(2):83-93.
[14] Wang C, Zeng W, Wang L, et al. Asprosin aggravates nonalcoholic fatty liver disease via inflammation and lipid metabolic disturbance mediated by reactive oxygen species[J]. Drug Dev Res, 2024,85(4):e22213.
[15] Lu Y, Yuan W, Xiong X, et al. Asprosin aggravates vascular endothelial dysfunction via disturbing mitochondrial dynamics in obesity models[J]. Obesity (Silver Spring), 2023,31(3):732-743.
[16] Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway[J]. Circulation, 2000,102(11):1296-1301.
[17] Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity[J]. Nat Med, 2001,7(8):941-946.
[18] Askin L, Duman H, Ozyildiz A, et al. Association between Omentin-1 and Coronary Artery Disease: Pathogenesis and Clinical Research[J]. Curr Cardiol Rev, 2020,16(3):198-201.
[19] Wang C, Wang Q, Mai H. Omentin-1 protects against endothelial dysfunction through the AMPK/KLF2/eNOS pathway in adult rat offspring exposed to maternal diabetes[J]. Nutr Diabetes, 2025,15(1):32.
[20] Askin L, Duman H, Ozyıldız A, et al. Association between Omentin-1 and Coronary Artery Disease: Pathogenesis and Clinical Research[J]. Current cardiology reviews, 2020,16(3):198-201.
[21] Zhou Q, Gao J, Wu G, et al. Adipose progenitor cell-derived extracellular vesicles suppress macrophage M1 program to alleviate midlife obesity[J]. Nature communications, 2025,16(1):2743.
[22] Duan H, Jing L, Xiang J, et al. CD146 Associates with Gp130 to Control a Macrophage Pro-inflammatory Program That Regulates the Metabolic Response to Obesity[J]. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022,9(13):e2103719.
[23] Yu X, Hu Y, Lim H Y, et al. Septal LYVE1(+) macrophages control adipocyte stem cell adipogenic potential[J]. Science (New York, N.Y.), 2025,389(6763):eadg1128.
[24] Peng C, Jiang H, Jing L, et al. Macrophage SUCLA2 coupled glutaminolysis manipulates obesity through AMPK[J]. Nature communications, 2025,16(1):1738.
[25] Gonzalez-Hurtado E, Leveau C, Li K, et al. Nerve-associated macrophages control adipose homeostasis across lifespan and restrain age-related inflammation[J]. Nature aging, 2025,5(9):1828-1843.
[26] Yang Y, Huang B, Qin Y, et al. Adipocyte microRNA-802 promotes adipose tissue inflammation and insulin resistance by modulating macrophages in obesity[J]. eLife, 2024,13:e99162.
[27] 涂永梅, 彭洁, 龙子, 等. PPAR-γ在巨噬细胞炎症调控中的作用及机制的研究进展[J]. 癌变·畸变·突变, 2022,34(02):158-161.
[28] Burgeiro A, Santos D, Fonseca A C R G, et al. Enhanced Mitochondrial Dynamics and Reactive Oxygen Species Levels with Reduced Antioxidant Defenses in Human Epicardial Adipose Tissue[J]. Metabolites, 2025,15(7):481.
[29] Gandoy-Fieiras N, Gonzalez-Juanatey J R, Eiras S. Myocardium Metabolism in Physiological and Pathophysiological States: Implications of Epicardial Adipose Tissue and Potential Therapeutic Targets[J]. International journal of molecular sciences, 2020,21(7):2641.
[30] Wiszniewski K, Grudniewska A, Szabłowska-Gadomska I, et al. Epicardial Adipose Tissue-A Novel Therapeutic Target in Obesity Cardiomyopathy[J]. International journal of molecular sciences, 2025,26(16):7963.
[31] Huang W, Xue Y, Zhou Y, et al. KLF7 promotes macrophage activation by activating the NF-κB signaling pathway in epicardial adipose tissue in patients with coronary artery disease[J]. European review for medical and pharmacological sciences, 2020,24(12):7002-7014.
[32] Hof A, Landerer M, Peitsmeyer P, et al. Myeloperoxidase impacts vascular function by altering perivascular adipocytes' secretome and phenotype in obesity[J]. Cell reports. Medicine, 2025,6(5):102087.